TScan Therapeutics Statistics

Total Valuation

TCRX has a market cap or net worth of $75.73 million. The enterprise value is $18.66 million.

Market Cap	75.73M
Enterprise Value	18.66M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, before market open.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

TCRX has 60.10 million shares outstanding. The number of shares has increased by 15.88% in one year.

Current Share Class	55.82M
Shares Outstanding	60.10M
Shares Change (YoY)	+15.88%
Shares Change (QoQ)	+128.84%
Owned by Insiders (%)	0.21%
Owned by Institutions (%)	43.41%
Float	50.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.45
Forward PS	9.58
PB Ratio	0.61
P/TBV Ratio	0.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.41, with a Debt / Equity ratio of 0.76.

Current Ratio	8.41
Quick Ratio	8.15
Debt / Equity	0.76
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-48.33

Financial Efficiency

Return on equity (ROE) is -71.28% and return on invested capital (ROIC) is -30.10%.

Return on Equity (ROE)	-71.28%
Return on Assets (ROA)	-27.88%
Return on Invested Capital (ROIC)	-30.10%
Return on Capital Employed (ROCE)	-63.69%
Weighted Average Cost of Capital (WACC)	5.70%
Revenue Per Employee	$72,711
Profits Per Employee	-$913,845
Employee Count	142
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.94% in the last 52 weeks. The beta is 1.01, so TCRX's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	-20.94%
50-Day Moving Average	1.09
200-Day Moving Average	1.40
Relative Strength Index (RSI)	58.70
Average Volume (20 Days)	1,356,625

Short Selling Information

The latest short interest is 942,877, so 1.57% of the outstanding shares have been sold short.

Short Interest	942,877
Short Previous Month	1.89M
Short % of Shares Out	1.57%
Short % of Float	1.87%
Short Ratio (days to cover)	0.95

Income Statement

In the last 12 months, TCRX had revenue of $10.33 million and -$129.77 million in losses. Loss per share was -$1.00.

Revenue	10.33M
Gross Profit	-102.23M
Operating Income	-133.81M
Pretax Income	-129.77M
Net Income	-129.77M
EBITDA	-130.95M
EBIT	-133.81M
Loss Per Share	-$1.00

Full Income Statement

Balance Sheet

The company has $152.41 million in cash and $94.14 million in debt, giving a net cash position of $58.27 million or $0.97 per share.

Cash & Cash Equivalents	152.41M
Total Debt	94.14M
Net Cash	58.27M
Net Cash Per Share	$0.97
Equity (Book Value)	123.12M
Book Value Per Share	2.16
Working Capital	138.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$135.32 million and capital expenditures -$4.41 million, giving a free cash flow of -$139.73 million.

Operating Cash Flow	-135.32M
Capital Expenditures	-4.41M
Depreciation & Amortization	2.87M
Net Borrowing	n/a
Free Cash Flow	-139.73M
FCF Per Share	-$2.32

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,296.01%
Pretax Margin	-1,256.81%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TCRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.88%
Shareholder Yield	-15.88%
Earnings Yield	-168.68%
FCF Yield	-181.63%

Analyst Forecast

The average price target for TCRX is $7.00, which is 455.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	455.56%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	59.74%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TCRX has an Altman Z-Score of -3.7 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.7
Piotroski F-Score	3